Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover
Bloomberg
Thursday, February 2, 2012 - 9:15am
tags:
Pfizer, Sutent, AB Science, masitinib, gastrointestinal cancer
AstraZeneca to cut 7,300 jobs, post lower profit
Marketwatch
Thursday, February 2, 2012 - 9:13am
tags:
layoffs, AstraZeneca, guidance
Pfizer Cites Packaging Flaws in Birth-Control Pill Recall
WSJ Online
Thursday, February 2, 2012 - 9:12am
tags:
Pfizer, recalls, packaging, birth control pill
J&J’s Zytiga for Prostate Cancer Too Expensive, U.K. Cost Agency Says
Bloomberg
Thursday, February 2, 2012 - 9:12am
tags:
JNJ, Zytiga, prostate cancer, UK
Pfizer: Why It's All In The Pipeline
Seeking Alpha
Wednesday, February 1, 2012 - 1:44pm
tags:
Pfizer, earnings, Lipitor, Lyrica, Xalatan, Pristiq
Medivation says prostate cancer pill MDV3100 met goal in second clinical trial
Yahoo/AP
Wednesday, February 1, 2012 - 12:21pm
tags:
Medivation, prostate cancer, MDV3100
Alnylam Gets New Patent
Yahoo/Zacks
Wednesday, February 1, 2012 - 12:20pm
tags:
Alnylam, patents, MC3 lipid
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
Seeking Alpha
Wednesday, February 1, 2012 - 12:19pm
tags:
Bristol-Myers Squibb, Ariad Pharmaceuticals, Inhibitex, Vertex Pharmaceuticals, Spectrum Pharmaceuticals, MannKind
Docs Are Surrendering To Generics: Survey
Pharmalot
Wednesday, February 1, 2012 - 12:16pm
tags:
physicians, generics
Allergan Pulls Doctor Payment Data From Web Site
Pharmalot
Wednesday, February 1, 2012 - 12:16pm
tags:
Allergan, physician payments
Dendreon And Provenge's True Median Life-Extension Benefit
Seeking Alpha
Wednesday, February 1, 2012 - 11:36am
tags:
prostate cancer, Provenge, Dendreon
Checking the Quality of Teva's Growth
Motley Fool
Wednesday, February 1, 2012 - 11:35am
tags:
Teva Pharmaceuticals
Are ISTA Pharmaceuticals' Numbers Better Than They Look?
Motley Fool
Wednesday, February 1, 2012 - 11:34am
tags:
Ista
Auxilium recieves cautious assessment for Xiaflex, says Leerink
Yahoo/Fly on the Wall
Wednesday, February 1, 2012 - 11:33am
tags:
Auxilium, Xiaflex, Pfizer, Dupuytren's Contracture, breast cancer, Eisai, Halaven
Impax Labs licenses Astrazeneca's migraine drug in US
Reuters
Wednesday, February 1, 2012 - 11:31am
tags:
AstraZeneca, Impax Labs, migraines, Zomig
Why CEO Replacement Is Good News For Dendreon
Forbes
Wednesday, February 1, 2012 - 11:30am
tags:
Dendreon, Pharma CEOs, Mitchell Gold
Roche Sees 2012 Profit Growth on New Drugs
Bloomberg
Wednesday, February 1, 2012 - 9:04am
tags:
Roche, guidance
Another Small Step Back For Mannkind
Seeking Alpha
Wednesday, February 1, 2012 - 9:03am
tags:
MannKind, Jentadueto, diabetes, Afrezza
Pfizer and Eli Lilly face generic drugs challenge
FT.com
Wednesday, February 1, 2012 - 9:02am
tags:
Eli Lilly, Pfizer, generics, patent cliff, earnings, Lipitor, Zyprexa
Pfizer recalls 1 million birth control packs for error that could cause unintended pregnancy
Yahoo/AP
Wednesday, February 1, 2012 - 9:01am
tags:
Pfizer, recalls, birth control pill, Lo-Ovral

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.